GlassScriptPhysician profile
Adam Scott Becker
NPI 1801060058
$2,757.66
in general payments reported to CMS, 2019-2025
14 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $53.85 · 2022: $1,200 · 2023: $890 · 2024: $229 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $808 · Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $807.84 |
| Food and Beverage | $551.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polaris Technology Solutions LLC | $1,200.00 | 2022 | |
| Arthrex, INC. | $448.48 | 2023 | |
| Seapearl East, INC | $401.51 | 2023-2025 | |
| Depuy Synthes Sales INC. | $242.46 | 2019-2024 | Na, Va-Lcp |
| Kerecis Limited | $110.85 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Orthofix Medical, INC. | $72.66 | 2024-2025 | Physio-Stim |
| Integra Lifesciences Corporation | $61.43 | 2019 | |
| Treace Medical Concepts, INC. | $58.59 | 2023 | |
| Axogen | $45.35 | 2019-2025 | |
| Hologic Sales and Service, LLC | $35.69 | 2025 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Djo, LLC | $29.83 | 2025 | Cmf |
| Zimmer Biomet Holdings, INC. | $21.01 | 2019 | |
| Heron Therapeutics, INC. | $15.90 | 2024 | Zynrelef |
| Amgen INC. | $13.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.